From clinical trials to regulatory submissions to HEOR research, the value of real-world data (RWD) is clear. So how are today’s pharma leaders using RWD in commercialization strategies, and where are the gaps in realizing its full potential?
This infographic reveals the results of Norstella’s survey of 200 life sciences executives about their use of RWD, its business impact, and their biggest barriers in maximizing its value.
Download the infographic today.
